Sign up to save your podcasts
Or
Share 230: BIO's messy transition, mRNA's future, & Biogen's next CEO
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
230: BIO's messy transition, mRNA's future, & Biogen's next CEO
STAT Washington correspondent Rachel Cohrs joins us to explain the abrupt departure of the CEO of BIO, the lobbying group representing biotech on Capitol Hill, and its wider implications. We also discuss the latest news in the life sciences, including the future of mRNA, a promising startup closing its doors, and Biogen’s search for a new CEO.
View all episodes
By STAT
4.5
303303 ratings
STAT Washington correspondent Rachel Cohrs joins us to explain the abrupt departure of the CEO of BIO, the lobbying group representing biotech on Capitol Hill, and its wider implications. We also discuss the latest news in the life sciences, including the future of mRNA, a promising startup closing its doors, and Biogen’s search for a new CEO.
More shows like The Readout Loud
View all
Planet Money
30,938 Listeners
a16z Podcast
1,022 Listeners
Odd Lots
1,780 Listeners
How I Built This with Guy Raz
30,252 Listeners
The Daily
111,276 Listeners
KFF Health News' 'What the Health?'
483 Listeners
The Long Run with Luke Timmerman
123 Listeners
Tradeoffs
383 Listeners
Biotech 2050 Podcast
59 Listeners
Business Of Biotech
87 Listeners
BioCentury This Week
30 Listeners
Raising Health
146 Listeners
Biotech Hangout
9 Listeners
Ground Truths
45 Listeners
Money Stuff: The Podcast
365 Listeners